CIK: 0002010850 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 8, 2025
Total Value ($000): $356,489 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 6,371,669 | $156,042 | 43.8% | $39.91 | -29.5% | COM | 156944100 |
| NUVB | Nuvation Bio Inc. | 25,954,439 | $45,680 | 12.8% | $3.05 | -25.4% | COM | 67080N101 |
| AARD | AARDVARK THERAPEUTICS INC | 3,917,299 | $29,419 | 8.3% | $11.23 | 0.0% | COM | 002942100 |
| UPB | Upstream Bio Inc. | 3,285,293 | $20,106 | 5.6% | $22.33 | -57.2% | COM | 91678A107 |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 770,000 | $15,762 | 4.4% | $19.66 | +13.1% | COM | N62509109 |
| KRYS | KRYSTAL BIOTECH INC | 65,000 | $11,720 | 3.3% | $121.63 | +38.3% | COM | 501147102 |
| RVMD | REVOLUTION MEDICINES INC(NSM) | 226,000 | $7,991 | 2.2% | $50.40 | -19.5% | COM | 76155X100 |
| — | MERUS NV | 189,098 | $7,959 | 2.2% | $51.07 | — | COM | N5749R100 |
| BYSI | BeyondSpring Inc. | 4,882,651 | $6,972 | 2.0% | $0.92 | +83.6% | SHS | G10830100 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 171,600 | $6,704 | 1.9% | $50.34 | — | COM | G4444C102 |
| — | Lyell Immunopharma, Inc. | 11,909,341 | $6,407 | 1.8% | $0.64 | — | COM | 55083R104 |
| RCUS | Arcus Biosciences, Inc | 808,789 | $6,349 | 1.8% | $15.98 | -27.5% | COM | 03969F109 |
| ACRS | Aclaris Therapeutics, Inc. | 4,041,736 | $6,184 | 1.7% | $2.33 | -8.5% | COM | 00461U105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 177,958 | $5,969 | 1.7% | $39.97 | -6.6% | COM | 22663K107 |
| CYTK | CYTOKINETICS INC | 100,000 | $4,019 | 1.1% | $75.83 | -39.4% | COM | 23282W605 |
| LEGN | LEGEND BIOTECH CORP-ADR | 100,000 | $3,393 | 1.0% | $47.77 | — | ADR | 52490G102 |
| ACLX | ARCELLX INC | 50,000 | $3,280 | 0.9% | $81.25 | -16.6% | COM | 03940C100 |
| ZNTL | Zentalis Pharmaceuticals Inc. | 2,019,762 | $3,211 | 0.9% | $13.39 | -83.9% | COM | 98943L107 |
| AURA | Aura Biosciences, Inc. | 515,555 | $3,021 | 0.8% | $8.47 | -10.7% | COM | 05153U107 |
| BNTX | Biontech SE-ADR | 20,000 | $1,821 | 0.5% | $113.95 | — | COM | 09075V102 |
| EQ | Equillium Inc. | 4,447,308 | $1,745 | 0.5% | $0.59 | +25.4% | COM | 29446K106 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 335,515 | $1,084 | 0.3% | $24.39 | -80.7% | COM | 35104E100 |
| ILMN | Illumnia, Inc. | 11,749 | $932 | 0.3% | $122.34 | -11.5% | COM | 452327109 |
| PYXS | Pyxis Oncology, Inc (formerly Apexigen) | 326,810 | $320 | 0.1% | $1.71 | -22.1% | COM | 747324101 |
| GRAL | GRAIL INC | 9,684 | $247 | 0.1% | $16.22 | +90.5% | COM | 384747101 |
| VERA | VERA THERAPEUTICS INC | 4,495 | $108 | 0.0% | $39.67 | -19.0% | COM | 92337R101 |
| — | Nuvation Bio Inc. | 646,057 | $44 | 0.0% | $0.16 | — | WARRANTS | 67080N119 |